Study on prevention mild to moderate Alzheimer's disease from exacerbating through invigorating spleen and kidney

onghua Hospital Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年3月6日

适应症

试验速览

暂无简介。

•1.The diagnostic criteria of Western medicine and traditional Chinese medicine for Alzheimer's disease was met;
•2.TCM syndrome differentiation belongs to the spleen and kidney deficiency type;
•3.Clinical dementia rating,Montreal Cognitive Assessment,Mini-mental State Examination scale was used to screen patients with mild to moderate Alzheimer's disease (referring to CDR scale score of CDR score 1 or 2 patients 10 points =MMSE score < 27 points);
•4.Both men and women aged 50-85 years old are acceptable;
•5.Informed consent was obtained from patients or their family members to voluntarily participate in this study.

•1.The diagnostic and inclusion criteria were not met;
•2.Patients with severe neurological deficits such as hemiplegia, aphasia, and visual and hearing impairment;
•3.Patients with cognitive impairment caused by other system diseases such as severe circulatory system, digestive system, urinary system, endocrine system and other diseases;
•4.Patients with underlying diseases affecting the oral absorption and metabolism of drugs;
•5.Patients with adverse addictions such as alcohol and drug abuse, psychotropic drug abuse and antidepressant drug abuse affected cognitive assessment;
•6.Patients with serious life-threatening primary diseases and mental disorders;
•7.People with allergic constitution;
•8.Taking other cognitive-improving Chinese medicine or Chinese patent medicine;
•9.Patients enrolled in other clinical trials within the past 3 months.

发起方

onghua Hospital Shanghai University of Traditional Chinese Medicine